Ambrx Biopharma Cayman, Inc. Quarterly Assets, Current in USD from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Assets, Current history and growth rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Assets, Current for the quarter ending June 30, 2023 was $241M, a 99.5% increase year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$241M	+$120M	+99.5%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$163M			Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$90.6M	-$86.2M	-48.8%	Dec 31, 2022	10-Q	2023-08-09
Q2 2022	$121M			Jun 30, 2022	6-K	2022-08-29
Q4 2021	$177M	+$83.7M	+90%	Dec 31, 2021	10-K	2023-03-30
Q4 2020	$93.1M			Dec 31, 2020	20-F	2022-04-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.